Search for: "Harris v. Amgen" Results 21 - 40 of 42
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Dec 2013, 6:12 am
Div. 2011) (citing §201.57 as authority for off-label drug warnings); see Harris v. [read post]
30 Aug 2012, 6:49 pm by Record on Appeal
Behrend – an antitrust case involving the issue of class certification (how much does the court look into the class during the certification stage);  Amgen Inc. v. [read post]
23 Jul 2012, 5:36 pm by Lyle Denniston
Harris — drug-sniffing dog’s “alert” as probable cause to search a car or truck Mon., Nov. 5: 11-864 — Comcast v. [read post]
19 Feb 2011, 3:32 pm
The subsequent case of Harris Corp. v. [read post]
18 Feb 2011, 4:11 pm by Lawrence B. Ebert
§ 282, or the “rebuttable presumption that different claims are of different scope,” Amgen Inc. v. [read post]
12 Sep 2008, 2:33 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Australian Review of National Innovation System released: (IPRoo), (Mallesons Stephen Jaques), (creativecommons.org), (IP Menu News), Senate Committee on the Judiciary approval of Enforcement of Intellectual Property Rights Act 2008 and surrounding debate (Law360), (Public Knowledge), (Ars Technica), (Wired), (Public Knowledge), (Ars Technica),… [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’… [read post]
18 Apr 2008, 2:00 am
Protecting computer programs under the Copyright Act: Dais Studios v Bullet Creative: (IP Down Under), Assessing copyright risk in new classroom technologies: (IP Down Under), Cadbury loses battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks Law Blog), (IP Down Under), (IPKat), (IPwar’s), Employee or independent contractor? [read post]
28 Mar 2008, 6:00 am
: (Afro-IP),If education and pricing policy fail, says Adobe in Nigeria, we can still sue: (Afro-IP),South African arm of Chrysler objects to advertisement by Indian vehicle maker Mahindra and Mahindra that uses the term "jeep": (Afro-IP), (Spicy IP),Kenya’s call for anti-counterfeit legislation… amongst other changes: (Afro-IP),Kenya: Shared computer use raises privacy, confidentiality issues: (Afro-IP)AustraliaChanges to grace period for trade mark renewal:… [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
22 Feb 2008, 1:30 pm
  The decision in Reidel v. [read post]